Michael Callegari, MD, MBA
-
Specialty: Urology
View Expertise -
Primary Location: 1120 E Broad St (26 mi.)
Other Locations - Languages Spoken: English
Office Locations
UH St John Health Campus (18 mi.)
29101 Health Campus Dr
Bldg 2 Ste 400
Westlake, OH 44145
440-617-4726
Biography: Michael Callegari, MD, MBA
Expertise
Education
Fellowship | Reconstructive Urology and Genitourinary Cancer
Reconstructive Urology and Genitourinary Cancer - Lahey Hospital And Medical Center (2024 - 2025)
Residency | Urology
Urology - UH Cleveland Medical Center (2019 - 2024)
Internship | General Surgery
General Surgery - UH Cleveland Medical Center (2018 - 2019)
Medical Education
University Of Oklahoma College Of Medicine (2018)
Other Education
University Of Tulsa (2015)
Undergraduate
University Of Tulsa (2013)
About
Michael Callegari, MD, MBA, is a fellowship-trained urologist at University Hospitals specializing in reconstructive and genitoplastic urologic surgery.
Originally from Oklahoma, Dr. Callegari completed his undergraduate and graduate education at the University of Tulsa before attending medical school at the University of Oklahoma. He then completed his urologic residency at Case Western Reserve University/ University Hospitals before completing a fellowship in genitourinary reconstruction at the Lahey Clinic in Boston.
Dr. Callegari’s primary clinical interests include the treatment of urethral stricture disease, fistulas, Peyronie's disease, male incontinence, erectile restoration and the surgical management of concealed penis and genital lymphedema. Additionally, he is experienced in and performs robotic minimally invasive surgical intervention for urinary reconstruction, management of neurogenic bladder and urinary diversion. Dr. Callegari also treats patients for many general urologic conditions including kidney stones and enlarged prostate.
In his spare time, Dr Callegari enjoys spending time with his family and dogs, traveling, playing golf and enjoying all things related to Sooner football and Thunder basketball.
Research & Publications
Research Links
PubMed
View Research
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Michael Callegari did not disclose any Outside Relationships with Industry.